Selegiline, also known as L-deprenyl and sold under the brand names Eldepryl, Zelapar, and Emsam among others, is a medication which is used in the treatment...
208 KB (20,184 words) - 19:38, 4 October 2024
pharmacology of selegiline pertains to the pharmacodynamic and pharmacokinetic properties of the antiparkinsonian and antidepressant selegiline (L-deprenyl)...
137 KB (13,990 words) - 17:20, 30 September 2024
Levoamphetamine (category Selegiline)
levoamphetamine is a known active metabolite of certain other drugs, such as selegiline (L-deprenyl). Levoamphetamine has been used in the treatment of attention...
62 KB (6,009 words) - 01:58, 22 September 2024
complicated by panic disorder or hysteroid dysphoria. Newer MAOIs such as selegiline (typically used in the treatment of Parkinson's disease) and the reversible...
37 KB (4,010 words) - 17:19, 13 October 2024
Deprenyl (category Selegiline)
N-propargylmethamphetamine, is the racemic mixture of D-deprenyl and L-deprenyl (selegiline). It was discovered in 1961 in Hungary at Chinoin Pharmaceutical Company...
7 KB (517 words) - 01:14, 30 September 2024
(PPAP; developmental code name MK-306) is an experimental drug related to selegiline which acts as a catecholaminergic activity enhancer (CAE). PPAP is a CAE...
28 KB (2,863 words) - 00:31, 30 September 2024
Levmetamfetamine (category Selegiline)
catecholamine releasing activity. It is 1- to 10-fold less potent than selegiline but is 3- to 5-fold more potent than dextromethamphetamine in this action...
49 KB (4,923 words) - 20:09, 29 September 2024
Monoaminergic activity enhancer (category Selegiline)
serotonergic activity. Selegiline's metabolite desmethylselegiline has also been found to be active as a CAE. Aside from selegiline and its metabolites,...
54 KB (5,655 words) - 03:41, 30 September 2024
Desmethylselegiline (category Selegiline)
an active metabolite of selegiline, a medication used in the treatment of Parkinson's disease and depression. Like selegiline, DMS is a monoamine oxidase...
19 KB (1,485 words) - 00:57, 20 August 2024
developmental code name FPFS-1169) is an experimental drug related to selegiline which acts as a monoaminergic activity enhancer (MAE). It is orally active...
30 KB (2,838 words) - 01:18, 16 September 2024